+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

After our two successful editions, we are glad to announce the 3rd Annual Epigenetics Discovery Congress, which will be taking place on the 12th - 13th of October 2017 in London, UK.

With a tremendous progress in technology to generate and analyze reference epigenomes, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas.  Additionally, novel epigenetic molecules across many target classes for drug discovery, have been the prime focus of the pharmaceutical industry.

To meet and support this pace of the epigenetics research and development field, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.

Post Show Report 2016

Click here to view post show report of the 2nd Annual Epigenetics Discovery Congress.

conference Registration Form



Academic Delegate£495
Industry Delegate £695
Solution Provider Delegate£995


Key Highlights
  • Epigenetics and disease
  • Modulation of the tumor microenvironment
  • bivalent inhibitors of BET bromodomains
  • Chemical Biology Tools for Target Identification and Validation
  • Epigenomics - Impact for Translational Safety Sciences
  • Epigenetic programming and Allergic Disease
  • Epigenetic regulation of biological ageing
  • Effect of environment on lifestyle
  • Transgenerational effects of epigenetics

For more information on the agenda of the conference, you can write to
 us at events@marketsandmarkets.com

Who Should Attend ?

Who should attend?

Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from

Pharmaceutical, Bio-pharmaceutical and Research Institutes working in

·         Epigenetics

·         Developmental Epigenetics

·         Epidemiology

·         Biology

·         Molecular Biology

·         Developmental Biology

·         Biomedical Sciences

·         Biological Sciences

·         Biochemistry

·         Medicinal Chemistry

·         Medicine

·         Genetics and Genomics

·         Developmental Genetics

·         Organic Chemistry

·         Natural Sciences

·         Translational sciences/medicines

Who Should Sponsor

·         Epigenetic Kits

Ø  Bisulfite Conversion Kits

Ø  ChIP-seq Kits

Ø  RNA Sequencing Kits

Ø  Whole Genome Amplification Kits

Ø  5-hmC and 5-mC Analysis Kits

·         Epigenetic Enzymes

Ø  DNA/Protein/RNA modifying Enzymes

·         Epigenetic Instruments

Ø  Genome Sequencing

Ø  Next Generation Sequencing

Ø  Single strand Sequencing

Ø  Peptide arrays

·         Epigenetic Reagents

Ø  Antibodies

Ø  Buffers

Ø  Histones

Ø  Magnetic Beads

Ø  Primers

Advisory Panel

  • Rab Prinjha
    VP, Head of Epinova Epigenetics DPU,
    GlaxoSmithKline, United Kingdom
  • Moshe Szyf
    Department of Pharmacology and Therapeutics,
    Glaxo Smith Kline and James McGill Professor,
    McGill University Medical School, Canada
  • Svetlana Hamm
    Head of Translational Pharmacology,
    4SC AG, Germany
  • Tony Bjourson
    Director of N. Ireland Centre for Stratified Medicine & Professor of Genomics,
    School of Biomedical Sciences,
    Ulster University, Ireland
  • Guro Elisabeth Lind
    Group leader Epigenetics, Department of Molecular Oncology,
    Institute for cancer research, Oslo University
  • Miguel Branco
    Senior Lecturer, Blizard Institute,
    Queen Mary University of London, United Kingdom


  • Christopher Schofield

    Head of Organic Chemistry, University of Oxford and fellow of Royal society, UK
  • David M. Wilson

    Senior Director & Head, Oncology Medicinal Chemistry, Astrazeneca, UK
  • James Flanagan

    Senior Lecturer, Cancer epigenetics Unit, Imperial College London, UK
  • Rémi Terranova

    Novartis Institutes for BioMedical Research, Switzerland
  • Miguel Branco

    Senior Lecturer, Blizard Institute, Queen Mary University of London, United Kingdom
  • Paul Hurd

    Senior Lecturer in Epigenetics, Queen Mary University of London, UK
  • Katherine West

    Lecturer in epigenetics, University of Glasgow, UK
  • Colum Walsh

    Professor of Genetics, University of Ulster, UK
  • Paul Shiels

    Professor, Epigenetics, University of Glasgow, UK
  • Gavin Kelsey

    Principal Research Scientist, Epigenetics Programme, The Babraham Institute, UK
  • Kilian Huber

    Group Leader, Principal Investigator, Group Head / PI, Member of congregation and Supervisor, University of Oxford, UK
  • Carlos Buesa

    CEO, Oryzon, Spain
  • Jesse Smith

    Vice President of Biological Sciences, Epizyme, USA
  • Rab Prinjha

    VP, Head of Epinova Epigenetics DPU, GlaxoSmithKline, UK
  • Brian Huntly

    Professor of Leukaemia Stem Cell Biology, University of Cambridge, UK
  • Jelena Mann

    Reader in Epigenetics, Newcastle University, UK
  • Jonathan Turner

    Principal Investigator, Deputy Head of Unit, Luxembourg Institute of Health, Luxembourg
  • Karen Lillycrop

    Senior Lecturer, Biomedical Sciences, University of Southampton, United Kingdom
  • John Holloway

    Associate Dean (Research), Professor of Allergy and Respiratory Genetics Faculty of Medicine University of Southampton, United kingdom
  • Guro Lind

    Professor, Dept. of Molecular oncology, University of Oslo, Norway
  • Paola Arimondo

    DR CNRS ETaC, France
  • Joëlle Rüegg

    Senior Researcher, Swetox & Dept. of Clinical Neuroscience, Karolinska Institutet, Sweden
  • Susan Clark

    Head of the Genome and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia
  • Gabriella Ficz

    Senior Lecturer, Barts Cancer Institute, Queens Mary University of
  • Andriana Margariti

    Senior Lecturer in Stem Cells and Vascular Diseases Queen’s University Belfast
  • Jane Cleal

    Lecturer in Epigenetics, University of Southampton, South Hampton, England
  • Rene Bartz

    Manager, Development Products, 4SC, Germany
  • Steve Conlan

    Head of Reproductive Biology and Gynecological Oncology, Swansea University Medical School






Diagenode is a global provider of complete solutions and services for epigenetics research, based in Liege, Belgium and NJ, USA. We offer innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality, validated antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. Our latest innovations include a low input RNA-seq kit, CRISPR/Cas 9 antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services.


Chromatrap is here to shake up the world of chromatin immunoprecipitation by offering researchers a new way of performing ChIP, effortlessly. By eliminating the use of convention beads, its revolutionary solid state system offers a more faster, easier and more sensitive method of performing ChIP. Our team continues to improve and innovate the technology and its protocols to ensure that researchers get the results they want, allowing them to focus on the bigger questions in epigenetics research.

Covaris - Sponsor - 3rd Annual Epigenetics Discovery Congress Covaris

Covaris is the recognized industry leader for DNA fragmentation.  Adaptive Focused Acoustics® (AFA™) is the gold standard for shearing DNA and RNA in Next-Generation Sequencing applications, without GC bias or thermal-induced damage. The Covaris AFA process is extensively cited in peer-reviewed research articles on DNA fragmentation using all available NGS systems.
Covaris Focused-ultrasonicators are recommended by all major sequencing platform providers, and are used by leading Genome Centers worldwide including: the Wellcome Trust Sanger Institute, the Broad Institute, and BGI. For more information, please visit: www.covaris.com.


Bioline is a primary manufacturer of high quality Molecular Biology reagents specialising in Gene Expression Analysis, Genotyping, Next Generation Sequencing, Biomarker Analysis, miRNA Research, Cloning, Nucleic Acid Purification and Custom Assay Development. We are part of the Meridian Bioscience group, providing clinical diagnostic and molecular research solutions that simplify, accelerate and improve life science research. Details on our new products as well as current offers are available from our friendly Sales Team at the Bioline booth.


Novogene Ltd is a leading genomic services and solutions provider with a cutting edge of next generation sequencing (NGS) and bioinformatics analysis expertise. The company has the largest sequencing capacities in the world at the moment and providing NGS service world-widely from universities to pharmaceutical companies. We are dedicated to delivering high-quality sequencing data and comprehensive bioinformatic analysis with excellent customer experience to help drive biotechnology research forward for our clients.


is the first company to have developed proprietary technologies permitting the collection, preservation and isolation of ALL the components of oral fluid; from the extracellular material (serum proteins, cell free DNA, bacteria, viruses) to the cells (including lymphocytes & T-cell populations), for at least several months, at varying temperatures. AboGen's technology enables genetic, epigenetic and proteomic studies, as well as biomarker discovery and diagnostic development, all from saliva.  Further, AboGen’s technology replaces blood, phlebotomy, needles, syringes and the logistical hassles of blood-donation, and permits the adoption of oral fluid as a superior paradigm over blood for research and for diagnostic applications. Blood cell extraction can now be done anywhere in the world via a home-based collection system.

Methyl Detect

Methyl Detect specializes in catalog and custom DNA methylation assays based on the methylation-sensitive high resolution melting (MS-HRM) technique. The MS-HRM method enables fast in-tube determination of the methylation status of the locus of interest in less than 3h, on widely-available lab equipment, from 50-200 ng of input DNA. Methyl Detect’s DNA methylation assays come supplied with gene-specific primers, and gene specific controls (methylation positive control, methylation negative control and an assay calibration control).


MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities


  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

 For sponsorship opportunities please contact us at events@marketsandmarkets.com


All Poster presentations will take place in breaks and alongside the breakout sessions of the congress.  All the presentation will be displayed in a dedicated area along with accepted posters from both industry & vendor delegates.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:

Email: events@marketsandmarkets.com

Academic delegatesFree
Industry and Solution Provider delegates£99

Posters Submission Form



Cancer Epigeneitcs SocietyCancer Epigenetics Society
Cancer Epigenetics Society is the first and largest society solely dedicated to cancer epigenetics. The Cancer Epigenetics Society promotes cancer epigenetics research and supports cancer patients worldwide by working on several fronts: the society publishes research articles on the basic, translational, preclinical, and clinical aspects of cancer epigenetics, provides scientists with several cancer epigenetics databases, produces scientific and educational videos, reports daily news that can help better manage or even prevent cancer, and provides access to cancer patient blogs, books, and advocacy and support groups. The Cancer Epigenetics Society is the official publisher of the journals Cancer Epigenetics and Clinical Cancer Epigenetics and awards annual prizes to the best research published in its journals from Society members. The society welcomes applications for membership (currently free) all year round.

The Epigenetics Society Epigenetics Society

The Epigenetics Society is an international scientific society open to all those interested in the epigenetics of any organism and all aspects of epigenetics, including:
> DNA methylation
> DNA hydroxymethylation
> Chromatin modification
> Chromatin higher-order-structure and remodeling
                                                 > Non-coding RNA related to chromatin structure or DNA modification

Membership in the society is free and provides a monthly e-news with “Abstracts in Press,” conference news, job postings and other announcements.


UK - PGxUK Pharmacogenetics and Stratified Medicine Network
The Pharmacogenetics and Stratified Medicine Network develops multidisciplinary partnerships between academics, clinicians, industry partners and regulators with patients, to promote the use of stratified medicine in the clinic. 
Through the Network groups of experts from academia, the healthcare sector, regulatory organisations and patient groups have the opportunity to collaborate to analyse patient samples, and interpret their data to stratify patients into the subcategory of their disease, then identify novel drug target sites and develop the much needed new drugs and diagnostics to make stratified medicine a reality in the clinic.


At EpigenomicsNet (and our sister journal Epigenomics), we provide a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships. Ultimately, we hope this dynamic network will provide a catalyst to accelerate progress and encourage collaboration in this ever-changing field. By joining the network and sharing your news and knowledge, you will be contributing towards the development of this exciting field. But, at a more personal level, this network also gives you the opportunity to connect with your peers and help gain knowledge and connections that may be useful to your work, whether it is research or regulation.

BioPartner UKBioPartner UK

BioPartner UK is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. BioPartner's delegations promote the UK presence at major international biopharma conferences, and companies are assisted with access to government grants and heavily discounted entry fees. Through the BioPartnership Programme, members receive extra benefits and support to effectively trade overseas.


3rd Annual Epigenetics Discovery Congress will be held at the Radisson Blu Edwardian Heathrow Hotel in London, UK.

Radisson Blu Edwardian Heathrow Hotel
Heathrow Airport
140 Bath Road, Hayes
Middlesex  UB3 5AW  England
LAT: 51.481529 LONG: -0.441432


For information on directions and transportation, please visit this link

Hotel Booking Link

Accommodation is currently available at the Radisson Blu Edwardian Heathrow Hotel at discounted rate. You will receive a link to book your accommodation via once you are fully registered. (Please note that we do not 
authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com).

About the Hotel

Minutes from Heathrow, Radisson Blu Edwardian, Heathrow is a 4 star airport hotel that feels like anything but. Dramatic spaces, distinctive design and dedicated service come together in a location where London meets the world. Rooms are spacious and deeply comfortable, and expansive spaces are ideal for entertaining and events on a grand scale. A buzzing Bijou Bar, new Steak & Lobster dining experience, Indian restaurant Annayu and soothing Pegasus Spa make this hotel perfect for work or play, and the ‘Stay, Park and Fly’ package gives you complimentary airport parking when you fly from Heathrow.

For further Information, please contact:
Email: events@marketsandmarkets.com